Drug Database
Back to search

Germany· DE-A57-9ebbc6875fb344a9

Verrucid

A salicylic acid product containing salicylic acid, registered in Germany by Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim. The same ATC class is registered in 6 of our 19 countries.

ATC D01AE12

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedVerrucidATCD01AE12REGISTER NO.DE-A57-9ebbc6875fb344…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about salicylic acidAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Salicylic acid is registered in 6 of 19 countries.

Countries holding a registration under ATC D01AE12 (salicylic acid), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 2 of them publish a price we can compare per daily dose
Search salicylic acid products by name

Salicylic acid · ATC D01AE12

6 / 19 countries

  • Belgiumprice
  • Germany
  • Ireland
  • Japan
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Salicylic Acid
Manufacturer
Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
Country
Germany (DE)
ATC code
D01AE12
ATC class
Salicylic acid
Defined daily dose
0.3 g, T
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

229 interactions on record for salicylic acid.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check salicylic acid against other medicinesHow interaction checks work

Salicylic acid · interactions on record

229 records

  • 16 severe
  • 182 moderate
  • 31 minor

Most severe, free to view

  • MethotrexateL01BA01severe
  • RamucirumabL01FG02severe
  • RamucirumabL01XC21severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Salicylic acid in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All salicylic acid products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Squamasol
  • Belgium · Aporil
  • Bulgaria · Салицилов Спирт Купро, Салицилов Спирт Химакс Фарма
  • Spain · Callicida Kendu, Unguento Morry
  • France · Ciella, Coricide Le Diable
  • United Kingdom (Northern Ireland) · Bazuka Extra Strength, Bazuka Extra Strength Treatment
  • Greece · Adaptoplast, Adaptoplast Callous Caps
  • Hungary · Spiritus Salicylatus Fono Viii. Naturland
  • Ireland · Carnation Callous Caps, Carnation Corn Caps
  • Italy · Acido Salicilico Marco Viti, Acido Salicilico Na
  • Lithuania · Salicilo Rūgštis Valentis
  • Luxembourg · Aporil
  • Latvia · Salicilskābe Valentis, Salicilskabes Rff
  • Netherlands · Formule W
  • Poland · Maść Na Odciski, Maść Na Odciski Gemi
  • Portugal · Calicida Indiano, Calicida Moreno
  • Sweden · Aco Acnegel, Aco Acnelösning

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c8633e1b-f7e8-447a-a0be-d54d0bc9cacd
GET /v1/drugs/c8633e1b-f7e8-447a-a0be-d54d0bc9cacd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Cutaneous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Salicylic Acid",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about salicylic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console